Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 13/20 | 0.71 |
| ▸ | GCGR | P47871 | 3/20 | 0.71 |
| ▸ | CALCR | P30988 | 3/20 | 0.69 |
| ▸ | CCKBR | P32239 | 4/20 | 0.65 |
| ▸ | NMBR | P28336 | 1/20 | 0.65 |
| ▸ | GRPR | P30550 | 1/20 | 0.65 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.64 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.64 |
| ▸ | GIPR | P48546 | 6/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182561 | 0.92 | GLP1R (0.68) | GLP1RGCGRCCKBRNMBRGRPR | |
| SCHEMBL30901423 | 0.92 | GLP1R (0.70) | GLP1RGCGRCALCRCCKBRGIPR | |
| SCHEMBL30537032 | 0.91 | CALCR (0.78) | GLP1RGCGRCALCRCCKBRNMBR | |
| SCHEMBL30658354 | 0.91 | CALCR (0.79) | GLP1RGCGRCALCRCCKBRNMBR | |
| SCHEMBL30658381 | 0.90 | GLP1R (0.67) | GLP1RGCGRCALCRCCKBR | |
| SCHEMBL30595937 | 0.89 | GLP1R (0.74) | GLP1RGCGRCALCRNMBRGRPR | |
| SCHEMBL30422794 | 0.89 | GLP1R (0.74) | GLP1RGCGRCALCRGIPR | |
| SCHEMBL30658237 | 0.89 | CALCR (0.76) | GLP1RGCGRCALCRCCKBRGIPR | |
| SCHEMBL30932077 | 0.89 | CALCR (0.76) | GLP1RGCGRCALCRCCKBRGIPR | |
| SCHEMBL29634488 | 0.89 | CALCR (0.75) | GLP1RGCGRCALCRCCKBRGIPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753627-B2 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-09-12 | — | — | US | disclosed |